- Home
- OPRX vs NVX Comparison
OPRX vs NVX Comparison
Compare OPRX & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPRX | NVX |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.6M | 235.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OPRX | NVX |
|---|---|---|
| Price | $10.82 | $0.91 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.67 | N/A |
| AVG Volume (30 Days) | 300.9K | ★ 1.3M |
| Earning Date | 03-05-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $109,506,000.00 | $5,931,433.00 |
| Revenue This Year | $19.77 | $165.90 |
| Revenue Next Year | $11.33 | $1,344.85 |
| P/E Ratio | $5,970.49 | ★ N/A |
| Revenue Growth | ★ 24.18 | N/A |
| 52 Week Low | $3.99 | $0.81 |
| 52 Week High | $22.25 | $3.86 |
Technical Indicators
Market Signals| Indicator | OPRX | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 36.31 |
| Support Level | $9.73 | $0.83 |
| Resistance Level | $11.91 | $0.99 |
| Average True Range (ATR) | 0.79 | 0.07 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 41.38 | 21.47 |
Price Performance
Historical ComparisonAbout OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.